Deletions within the lymphoid transcription factor IKAROS family zinc finger 1 (IKZF1), either alone or in combination with other genomic features, have been independently associated with poorer outcomes in patients with B-ALL and have been recognized in some risk stratification algorithms [5,6,7]. Here, IKZF1 is linked to acute lymphoblastic leukemia.